Brief: Arch Biopartners To Seek Regulatory Guidance From The U.S FDA For AB569

Arch Biopartners

19/06/2018 13:13

June 19 (Reuters) - 
    * ARCH BIOPARTNERS TO SEEK REGULATORY GUIDANCE FROM THE U.S
FDA
FOR AB569
    * ARCH BIOPARTNERS INC - WILL SEEK REGULATORY GUIDANCE FROM
U.S.
FDA IN A PRE-INVESTIGATIONAL NEW DRUG APPLICATION MEETING FOR
AB569
    * ARCH BIOPARTNERS - INVESTIGATOR-INITIATED PHASE I SAFETY
TRIAL
WILL BE ON HOLD, TO RESUME AFTER IND APPLICATION IS OPENED & FDA
APPROVES PHASE I STUDY
    * ARCH - DATA ACCUMULATED FROM INVESTIGATOR INITIATED STUDY
AT
CVAMC INSUFFICIENT TO MAKE RELIABLE DISCLOSURE REGARDING SAFETY
OF AB569

Source text for Eikon:  ID:nGNX1NH5j8 

 ((Reuters.Briefs@thomsonreuters.com;))